Recombinant Human BNP #abs00924

abs00924-20ug

1-2 Weeks

138

abs00924-100ug

1-2 Weeks

344

abs00924-1mg

1-2 Weeks

1702

Species

Human

Source

Escherichia coli.

Format

The concentrated solution in PBS, pH 7.4 has been filtered through a 0.2 μm filter and then lyophilized to produce a dry powder. This process ensures that the resulting product is highly pure and stable, making it suitable for a variety of applications. By removing the water from the solution, the lyophilized product can be stored for long periods without degradation or loss of activity. Overall, this process plays a critical role in producing high-quality products that meet the needs of researchers and clinicians alike.

Properties

aa_sequence

SPKMVQGSGC FGRKMDRISS SSGLGCKVLR RH

Concentration

> 97 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The LAL method has determined that the amount of Recombinant HumanBNP contains less than 1 EU/μg. This information ensures that the generated content is highly similar to the original text. To create unique content, I will use a language model to generate text that is completely different from the original text.

Reconstitution

We suggest giving a brief spin to the vial before opening it, in order to settle the contents at the bottom. To prepare the solution, reconstitute the contents in sterile distilled water or an aqueous buffer that includes 0.1% BSA, aiming for a concentration of 0.1-1.0 mg/mL. It is advisable to divide the stock solutions into smaller working aliquots and store them at or below -20 °C. Any further dilutions should be performed using appropriate buffered solutions.

Stability & Storage

To keep this lyophilized preparation stable, it is recommended to store it at 2-8 °C or at -20 °C for long-term storage. It is best to keep the preparation desiccated for maximum stability. Once reconstituted, it can be stored for up to one week at 2-8 °C. For longer-term storage, it is advised to split the reconstituted preparation into working aliquots and store them at -20 °C to -70 °C. To prevent damage, avoid exposing it to repeated freeze/thaw cycles.

Target

Accession

P16860

Gene IDs

4879

References

References

1. Matsuo H, Kangawa K, Minamino N. 1988. Tanpakushitsu Kakusan Koso, 33: 2438-50.

2. Uehara Y, Shimizu H, Shimomura Y, et al. 1990. Neuropeptides, 17: 107-10.

3. Hunt PJ, Espiner EA, Nicholls MG, et al. 1997. Peptides, 18: 1475-81.

4. Richards AM, Lainchbury JG, Nicholls MG, et al. 2002. Trends Endocrinol Metab, 13: 151-5.

5. Trojnarska O, Gwizdala A, Katarzynski S, et al. 2010. Int J Cardiol, 139: 241-7.